DZ3292A1 - Nouveaux composes de type 1-[1-(hetero)aryl-1-perhydroxyalkylmethyl]piperazine, methodes pour les preparer et medicaments renfermant cescomposes - Google Patents
Nouveaux composes de type 1-[1-(hetero)aryl-1-perhydroxyalkylmethyl]piperazine, methodes pour les preparer et medicaments renfermant cescomposesInfo
- Publication number
- DZ3292A1 DZ3292A1 DZ020227A DZ020227A DZ3292A1 DZ 3292 A1 DZ3292 A1 DZ 3292A1 DZ 020227 A DZ020227 A DZ 020227A DZ 020227 A DZ020227 A DZ 020227A DZ 3292 A1 DZ3292 A1 DZ 3292A1
- Authority
- DZ
- Algeria
- Prior art keywords
- compounds
- perhydroxyalkylmethyl
- hetero
- aryl
- novel
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/092—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Indole Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10145044A DE10145044A1 (de) | 2001-09-13 | 2001-09-13 | Neue 1-[1-(Hetero)aryl-1-perhydroxyalkylmethyl]-Piperazinverbindungen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DZ3292A1 true DZ3292A1 (fr) | 2005-05-14 |
Family
ID=7698848
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DZ020227A DZ3292A1 (fr) | 2001-09-13 | 2000-09-14 | Nouveaux composes de type 1-[1-(hetero)aryl-1-perhydroxyalkylmethyl]piperazine, methodes pour les preparer et medicaments renfermant cescomposes |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6770649B2 (en:Method) |
| EP (1) | EP1293506B1 (en:Method) |
| JP (1) | JP4353684B2 (en:Method) |
| KR (1) | KR100909746B1 (en:Method) |
| CN (1) | CN1232513C (en:Method) |
| AR (1) | AR036487A1 (en:Method) |
| AT (1) | ATE305464T1 (en:Method) |
| AU (1) | AU2002301141B2 (en:Method) |
| BR (1) | BR0203716A (en:Method) |
| CA (1) | CA2403139C (en:Method) |
| DE (2) | DE10145044A1 (en:Method) |
| DK (1) | DK1293506T3 (en:Method) |
| DZ (1) | DZ3292A1 (en:Method) |
| ES (1) | ES2250561T3 (en:Method) |
| HU (1) | HU227612B1 (en:Method) |
| IL (1) | IL151497A (en:Method) |
| MX (1) | MXPA02008789A (en:Method) |
| NO (1) | NO324867B1 (en:Method) |
| NZ (1) | NZ521154A (en:Method) |
| PL (1) | PL356018A1 (en:Method) |
| PT (1) | PT1293506E (en:Method) |
| RU (1) | RU2301807C2 (en:Method) |
| SI (1) | SI1293506T1 (en:Method) |
| TW (1) | TWI254046B (en:Method) |
| UA (1) | UA75590C2 (en:Method) |
| ZA (1) | ZA200206731B (en:Method) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2603030C (en) | 2005-03-31 | 2013-11-19 | Nippon Zoki Pharmaceutical Co., Ltd. | Benzyloxypropylamine derivative |
| RU2419609C2 (ru) * | 2005-11-30 | 2011-05-27 | Зольвай Фармасьютиклз Гмбх | Новые антагонисты nk1 и nk2 |
| US7592344B2 (en) | 2005-11-30 | 2009-09-22 | Solvay Pharmaceuticals Gmbh | NK1 and NK2-antagonists and compositions and methods of using the same |
| CN103387549A (zh) * | 2012-05-10 | 2013-11-13 | 广州医学院 | 三个苯并三氮唑类芳基哌嗪化合物的消旋体和光学异构体及其制备方法和用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1575904A (en) * | 1976-04-23 | 1980-10-01 | Lilly Industries Ltd | Phenyl piperazines |
| IE903957A1 (en) * | 1989-11-06 | 1991-05-08 | Sanofi Sa | Aromatic amine compounds, their method of preparation and¹pharmaceutical compositions in which they are present |
| IL99320A (en) * | 1990-09-05 | 1995-07-31 | Sanofi Sa | Arylalkylamines, their preparation and pharmaceutical compositions containing them |
| DE69534213T2 (de) * | 1994-10-25 | 2006-01-12 | Astrazeneca Ab | Therapeutisch wirksame Heterocyclen |
| JP2003530381A (ja) * | 2000-04-06 | 2003-10-14 | アストラゼネカ・アクチエボラーグ | 化合物 |
-
2000
- 2000-09-14 DZ DZ020227A patent/DZ3292A1/fr active
-
2001
- 2001-09-13 DE DE10145044A patent/DE10145044A1/de not_active Withdrawn
-
2002
- 2002-08-15 TW TW091118380A patent/TWI254046B/zh not_active IP Right Cessation
- 2002-08-22 ZA ZA200206731A patent/ZA200206731B/xx unknown
- 2002-08-22 AR ARP020103153A patent/AR036487A1/es active IP Right Grant
- 2002-08-27 IL IL151497A patent/IL151497A/en not_active IP Right Cessation
- 2002-09-03 NZ NZ521154A patent/NZ521154A/en not_active IP Right Cessation
- 2002-09-06 KR KR1020020053771A patent/KR100909746B1/ko not_active Expired - Fee Related
- 2002-09-07 ES ES02020115T patent/ES2250561T3/es not_active Expired - Lifetime
- 2002-09-07 EP EP02020115A patent/EP1293506B1/de not_active Expired - Lifetime
- 2002-09-07 AT AT02020115T patent/ATE305464T1/de active
- 2002-09-07 DE DE50204379T patent/DE50204379D1/de not_active Expired - Lifetime
- 2002-09-07 SI SI200230195T patent/SI1293506T1/sl unknown
- 2002-09-07 DK DK02020115T patent/DK1293506T3/da active
- 2002-09-07 PT PT02020115T patent/PT1293506E/pt unknown
- 2002-09-09 MX MXPA02008789A patent/MXPA02008789A/es active IP Right Grant
- 2002-09-09 HU HU0202967A patent/HU227612B1/hu not_active IP Right Cessation
- 2002-09-11 CN CNB021315566A patent/CN1232513C/zh not_active Expired - Fee Related
- 2002-09-11 UA UA2002097386A patent/UA75590C2/uk unknown
- 2002-09-11 JP JP2002265969A patent/JP4353684B2/ja not_active Expired - Fee Related
- 2002-09-12 AU AU2002301141A patent/AU2002301141B2/en not_active Ceased
- 2002-09-12 BR BR0203716-5A patent/BR0203716A/pt not_active IP Right Cessation
- 2002-09-12 RU RU2002124199/04A patent/RU2301807C2/ru not_active IP Right Cessation
- 2002-09-12 PL PL02356018A patent/PL356018A1/xx not_active Application Discontinuation
- 2002-09-12 NO NO20024351A patent/NO324867B1/no not_active IP Right Cessation
- 2002-09-13 US US10/242,678 patent/US6770649B2/en not_active Expired - Lifetime
- 2002-09-13 CA CA2403139A patent/CA2403139C/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0203136A3 (en) | Piperazine compounds, process for their preparation, pharmaceutical compositions containing them and their use | |
| IL138568A0 (en) | 1-[(1-substituted-4-piperidinyl) methyl] -4- piperidine derivative, process for the preparation thereof, pharmaceutical composition containing the same and intermediate therefor | |
| IL151202A0 (en) | Phenyl derivatives, a process for their praparation, pharmaceutical compositions containing them, a process for preparing the pharmaceutical compositions, and their use in therapy | |
| HUP0301651A2 (en) | Indolylmaleimide derivatives, pharmaceutical compositions containing them, process for producing them and their use | |
| ZA997733B (en) | Hydrazide compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| HUP0002843A3 (en) | New betha-carboline compounds, a process for their preparation and pharmaceutical compositions containing them | |
| ZA200105394B (en) | Diphenylurea compounds, a process for their preparation and pharmaceutical composition containing them. | |
| IL150377A0 (en) | Substituted piperidines, medicaments containing these compounds, and methods for the production thereof | |
| HUP0104779A3 (en) | Antihistaminic spiro compounds, process for their preparation and medicaments containing them | |
| ZA200100864B (en) | Piperidine-4-sulphonamides compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| HUP0104272A3 (en) | New cyclobutendione compounds, a process for their preparation and pharmaceutical compositions containing them | |
| HU0100274D0 (en) | New benzenesulphonamide compounds, process for their preparation and pharmaceutical compositions containing them | |
| PL360090A1 (en) | Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same | |
| HUP0202379A3 (en) | New compounds, process for producing them and pharmaceutical compositions containing them | |
| IL151497A0 (en) | Novel 1-[1-(hetero)aryl-1-perhydroxyalkylmethyl]-piperazine compounds, process for their preparation and medicaments containing these compounds | |
| HUP0200376A3 (en) | Thiaoloindolinone compounds, process for their preparation and pharmaceutical composions containing them and their use | |
| AU9424601A (en) | Novel aliphatic compounds, process for their preparation and their usage | |
| HUP0301008A3 (en) | New imidazole derivatives, process for their preparation, their use and pharmaceutical compositions containing them | |
| ZA200202030B (en) | Isoindoloindolone compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| HUP0102830A3 (en) | Antidiabetic piperazine derivatives, process for their preparation and pharmaceutical compositions containing them | |
| ZA200202220B (en) | Indenoindolone compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| ZA200205666B (en) | N-benzylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| HUP0204444A3 (en) | Phenyl- and pyridyl-tetrahydro-pyridines, process for their preparation and pharmaceutical compositions containing them | |
| AU2002301141A1 (en) | Novel 1-[-(hetero)aryl-1-perhydroxyalkylmethyl])-piperazine compounds, process for their preparation and medicaments containing these compounds | |
| HUP0001249A3 (en) | Novel substituted dimeric compounds, process for their production and medicaments containing the same |